3 Things You Need to Know If You Buy Pfizer Today

Pfizer (NYSE: PFE) has been around for 175 years, but the company's revenue soared to its highest ever only in more recent times. Thanks to its coronavirus treatment and vaccine, the pharma giant reported more than $100 billion in revenue in 2022 at the peak of its pandemic success. Since that time, though, demand for these products has declined, and that's resulted in lower revenue and a drop in the Pfizer share price.Right now, as an investor, you may be wondering if you should take advantage of the stock's lower valuation and dive in or avoid this struggling stock. Before making any decisions, it's important to take a look at Pfizer's strategy and the company's prospects over time. Here are three things you need to know if you buy Pfizer today.Image source: Getty Images.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool